Abstract:ABSTRACT Hepatitis B virus (HBV) infection causes chronic hepatitis in hundreds of millions of people worldwide, which can eventually lead to hepatocellular carcinoma (HCC). Previously, we found that HBV mRNAs can absorb microRNA-15a (miR-15a) to affect apoptosis through the Bcl-2 pathway. We asked whether HBV could inhibit apoptosis and promote tumorigenesis through different pathways. In this study, we found that the transforming growth factor β (TGF-β) pathway-inhibitory factor Smad7 is a novel target of miR-15a. We demonstrated that HBV can upregulate the level of Smad7 by downregulating miR-15a. Furthermore, we examined the level of Smad7 in liver samples from HBV-infected HCC patients and found that HBV mRNAs are positively correlated with the level of Smad7. By taking the approach of using immunoblotting and luciferase reporter assays, we revealed that HBV can abrogate TGF-β signaling via upregulating Smad7. By using annexin V staining and caspase 3/7 activity assays, we found that HBV can inhibit TGF-β-induced apoptosis of HepG2 cells. We also showed that HBV can promote tumor growth in BALB/c nude mice through upregulating the expression of Smad7. In conclusion, we demonstrated that HBV can upregulate Smad7 expression and inhibit TGF-β signaling, which makes the cells resistant to TGF-β-induced apoptosis and promotes tumorigenesis. IMPORTANCE Hepatitis B virus (HBV) infection causes chronic hepatitis, which can eventually lead to hepatocellular carcinoma (HCC). TGF-β signaling is closely linked to liver fibrosis, cirrhosis, and subsequent HCC progression and plays a unique role in the pathogenesis of HCC. At the early stage of tumor formation, TGF-β functions as a tumor suppressor that inhibits cell proliferation and induces apoptosis. Previously, we found that HBV mRNAs can sponge off miR-15a to affect apoptosis through the Bcl-2 pathway. In this study, we identified that the TGF-β-inhibitory factor Smad7 is a novel target of miR-15a. We reveal that HBV can abrogate TGF-β signaling via upregulating Smad7, inhibit TGF-β-induced apoptosis, as well as promote tumor development. Our study provides evidence to support the idea that viral RNAs can exert their functions as competing endogenous RNAs (ceRNAs) toward microRNA and participate in important cellular processes.

Ectopic expression of microRNA-155 enhances innate antiviral immunity against HBV infection in human hepatoma cells

MicroRNA Profile in HBV-induced Infection and Hepatocellular Carcinoma.

Modulation of HBV Replication by Microrna-15B Through Targeting Hepatocyte Nuclear Factor 1Α

An HBV-encoded miRNA activates innate immunity to restrict HBV replication

Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1.

Mir146a Impairs the Ifn-Induced Anti-Hbv Immune Response by Downregulating Stat1 in Hepatocytes

Lower Expression of MicroRNA-155 Contributes to Dysfunction of Natural Killer Cells in Patients with Chronic Hepatitis B

Hepatitis B Viral RNA Directly Mediates Down-regulation of the Tumor Suppressor MicroRNA miR-15a/miR-16-1 in Hepatocytes

MicroRNAs may solve the mystery of chronic hepatitis B virus infection.

Hepatitis B Virus Inhibits Intrinsic RIG-I and RIG-G Immune Signaling Via Inducing Mir146a

Down-expression of miR-152 lead to impaired anti-tumor effect of NK via upregulation of HLA-G

Expression of MicroRNA-155 is Downregulated in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B Patients.

Up-regulated Expression of Mir-181A in HepG2.2.15 Cells Transfected Via Full-Length Hepatitis B Virus Genome

MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B.

Up-regulated MicroRNA-181a Induces Carcinogenesis in Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting E2F5

Hepatitis C Virus-Induced Up-Regulation of Microrna-155 Promotes Hepatocarcinogenesis by Activating Wnt Signaling.

MiR-185-5p Suppresses HBV Gene Expression by Targeting ELK1 in Hepatoma Carcinoma Cells

Hepatitis B Virus Regulates Apoptosis and Tumorigenesis Through the MicroRNA-15a-Smad7-Transforming Growth Factor Beta Pathway

Hepatitis B Virus Induces Autophagy to Promote its Replication by the Axis of miR-192-3p-XIAP via NF-κB Signaling.

MicroRNA‐155 Regulates Interferon‐γ Production in Natural Killer Cells Via Tim‐3 Signalling in Chronic Hepatitis C Virus Infection

Inducible Microrna-155 Feedback Promotes Type I IFN Signaling in Antiviral Innate Immunity by Targeting Suppressor of Cytokine Signaling 1.